Micro Cap Growth Fund
Daily price w/o sales charge as of 03/28/2024
$14.93
$0.06
YTD Returns w/o sales charge as of 03/28/2024
7.64%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 02/29/2024
- Total Net Assets
- $197.07 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.37%
- Fund Net Expense Ratio
- 1.37%
- Number of Holdings
- 71
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | 5.70% | 3.46% | -11.53% | 9.65% | 10.37% | 9.81% |
Lipper Category Avg. Small-Cap Growth Funds | 5.56% | 13.95% | -2.95% | 8.18% | 8.26% | - |
Russell Microcap® Growth Index | 5.28% | 7.32% | -12.29% | 3.62% | 3.41% | - |
w/ sales charge | -0.41% | -2.46% | -13.26% | 8.35% | 9.72% | 9.53% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | 5.88% | 5.88% | -8.15% | 13.35% | 10.92% | 9.62% |
Lipper Category Avg. Small-Cap Growth Funds | 16.76% | 16.76% | -2.40% | 10.73% | 7.93% | - |
Russell Microcap® Growth Index | 9.11% | 9.11% | -8.22% | 5.97% | 3.67% | - |
w/ sales charge | -0.22% | -0.22% | -9.94% | 12.01% | 10.26% | 9.35% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 02/29/2024View Portfolio
Holding | Assets |
---|---|
JFrog Ltd | 3.0% |
RxSight Inc | 2.9% |
Modine Manufacturing Co | 2.7% |
AvidXchange Holdings Inc | 2.5% |
First Watch Restaurant Group Inc | 2.3% |
TransMedics Group Inc | 2.3% |
AeroVironment Inc | 2.2% |
Green Brick Partners Inc | 2.1% |
Weave Communications Inc | 2.1% |
Krystal Biotech Inc | 2.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/29/2024View Portfolio
Sector | Weighting |
---|
Sector | Weighting |
---|---|
Communication Services | |
Real Estate | |
Utilities | |
Consumer Discretionary | |
Consumer Staples | |
Energy | |
Financials | |
Health Care | |
Industrials | |
Information Technology | |
Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | 5.70% | 3.46% | -11.53% | 9.65% | 10.37% | 9.81% |
Lipper Category Avg. Small-Cap Growth Funds | 5.56% | 13.95% | -2.95% | 8.18% | 8.26% | - |
Russell Microcap® Growth Index | 5.28% | 7.32% | -12.29% | 3.62% | 3.41% | - |
w/ sales charge | -0.41% | -2.46% | -13.26% | 8.35% | 9.72% | 9.53% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
---|
w/o sales charge | 5.88% | 5.88% | -8.15% | 13.35% | 10.92% | 9.62% |
Lipper Category Avg. Small-Cap Growth Funds | 16.76% | 16.76% | -2.40% | 10.73% | 7.93% | - |
Russell Microcap® Growth Index | 9.11% | 9.11% | -8.22% | 5.97% | 3.67% | - |
w/ sales charge | -0.22% | -0.22% | -9.94% | 12.01% | 10.26% | 9.35% |
Fund Expense Ratio :
Gross 1.37%
Net 1.37%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
Year | Fund Returns | Russell Microcap® Growth Index |
---|
2023 | 5.88% | 9.11% |
2022 | -29.27% | -29.76% |
2021 | 3.46% | 0.88% |
2020 | 79.42% | 40.13% |
2019 | 34.57% | 23.33% |
2018 | 2.74% | -14.18% |
2017 | 38.43% | 16.65% |
2016 | 2.07% | 6.86% |
2015 | -6.38% | -3.85% |
2014 | 10.83% | 4.30% |
2013 | 78.53% | - |
2012 | 2.35% | - |
2011 | -5.87% | - |
2010 | 33.77% | - |
2009 | 52.61% | - |
2008 | -46.45% | - |
2007 | 22.76% | - |
2006 | 25.37% | - |
2005 | 2.55% | - |
2004 | 25.89% | - |
Year | Q1 | Q2 | Q3 | Q4 |
---|
2024 | - | - | - | - |
2023 | 5.50% | 4.20% | -13.40% | 11.23% |
2022 | -17.22% | -22.57% | 8.17% | 2.02% |
2021 | 12.29% | -0.15% | -9.42% | 1.87% |
2020 | -24.28% | 47.61% | 17.48% | 36.65% |
2019 | 22.67% | 7.47% | -13.91% | 18.57% |
2018 | 5.24% | 15.77% | 10.08% | -23.39% |
2017 | 9.00% | 8.12% | 13.61% | 3.39% |
2016 | -13.70% | 6.01% | 14.49% | -2.55% |
2015 | 7.33% | 4.15% | -16.30% | 0.06% |
2014 | 7.92% | -6.53% | -6.55% | 17.58% |
2013 | 21.83% | 15.00% | 17.29% | 8.65% |
2012 | 17.67% | -9.76% | 1.32% | -4.87% |
2011 | 4.82% | 0.11% | -21.90% | 14.86% |
2010 | 6.60% | -8.74% | 15.08% | 19.49% |
2009 | -0.95% | 31.46% | 13.47% | 3.29% |
2008 | -23.22% | 4.46% | -5.93% | -29.02% |
2007 | 5.64% | 9.81% | 4.01% | 1.76% |
2006 | 17.15% | -9.83% | 1.22% | 17.25% |
2005 | -9.50% | 5.88% | 6.91% | 0.10% |
2004 | 12.33% | 1.65% | -11.11% | 24.03% |
2003 | -3.55% | 27.29% | 11.68% | 8.93% |
2002 | -0.18% | -12.74% | -21.79% | 1.33% |
2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 02/29/2024
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
Date | Net Asset Value |
---|
Portfolio
Portfolio
Holding | Sector | Assets |
---|
JFrog Ltd | Information Technology | 3.0% |
RxSight Inc | Health Care | 2.9% |
Modine Manufacturing Co | Consumer Discretionary | 2.7% |
AvidXchange Holdings Inc | Financials | 2.5% |
First Watch Restaurant Group Inc | Consumer Discretionary | 2.3% |
TransMedics Group Inc | Health Care | 2.3% |
AeroVironment Inc | Industrials | 2.2% |
Green Brick Partners Inc | Consumer Discretionary | 2.1% |
Weave Communications Inc | Information Technology | 2.1% |
Krystal Biotech Inc | Health Care | 2.0% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Holding | Sector | Assets |
---|
RxSight Inc | Consumer, Non-cyclical | 3.0% |
TransMedics Group Inc | Consumer, Non-cyclical | 2.8% |
Rambus Inc | Technology | 2.6% |
AeroVironment Inc | Industrial | 2.5% |
Cymabay Therapeutics Inc | Consumer, Non-cyclical | 2.5% |
JFrog Ltd | Technology | 2.4% |
Weave Communications Inc | Technology | 2.2% |
AvidXchange Holdings Inc | Technology | 2.2% |
Modine Manufacturing Co | Industrial | 2.2% |
CVRx Inc | Consumer, Non-cyclical | 2.1% |
First Watch Restaurant Group Inc | Consumer, Cyclical | 2.0% |
Alkami Technology Inc | Technology | 2.0% |
Green Brick Partners Inc | Consumer, Cyclical | 2.0% |
OSI Systems Inc | Industrial | 2.0% |
Arcellx Inc | Consumer, Non-cyclical | 1.9% |
Sterling Infrastructure Inc | Industrial | 1.8% |
Agilysys Inc | Technology | 1.8% |
Coursera Inc | Consumer, Non-cyclical | 1.7% |
LiveRamp Holdings Inc | Consumer, Non-cyclical | 1.7% |
Stride Inc | Consumer, Non-cyclical | 1.7% |
Rhythm Pharmaceuticals Inc | Consumer, Non-cyclical | 1.7% |
Credo Technology Group Holding Ltd | Communications | 1.7% |
Yelp Inc | Communications | 1.7% |
Crinetics Pharmaceuticals Inc | Consumer, Non-cyclical | 1.6% |
Quanterix Corp | Consumer, Non-cyclical | 1.6% |
ICF International Inc | Consumer, Non-cyclical | 1.5% |
elf Beauty Inc | Consumer, Non-cyclical | 1.5% |
Krystal Biotech Inc | Consumer, Non-cyclical | 1.5% |
Integral Ad Science Holding Corp | Technology | 1.4% |
Kura Sushi USA Inc | Consumer, Cyclical | 1.4% |
Piper Sandler Cos | Financial | 1.4% |
Longboard Pharmaceuticals Inc | Consumer, Non-cyclical | 1.4% |
NerdWallet Inc | Financial | 1.3% |
Paymentus Holdings Inc | Consumer, Non-cyclical | 1.3% |
Bancorp Inc/The | Financial | 1.3% |
Varonis Systems Inc | Technology | 1.3% |
UFP Technologies Inc | Consumer, Non-cyclical | 1.3% |
MoonLake Immunotherapeutics | Consumer, Non-cyclical | 1.2% |
Shake Shack Inc | Consumer, Cyclical | 1.2% |
Zeta Global Holdings Corp | Technology | 1.2% |
Oddity Tech Ltd | Technology | 1.2% |
Fastly Inc | Technology | 1.2% |
Xenon Pharmaceuticals Inc | Consumer, Non-cyclical | 1.1% |
PROCEPT BioRobotics Corp | Consumer, Non-cyclical | 1.1% |
Verra Mobility Corp | Technology | 1.1% |
Blue Bird Corp | Consumer, Cyclical | 1.1% |
Remitly Global Inc | Consumer, Non-cyclical | 1.1% |
Photronics Inc | Technology | 1.0% |
Primoris Services Corp | Industrial | 1.0% |
TaskUS Inc | Technology | 1.0% |
Fusion Pharmaceuticals Inc | Consumer, Non-cyclical | 1.0% |
Vital Farms Inc | Consumer, Non-cyclical | 0.9% |
Twist Bioscience Corp | Consumer, Non-cyclical | 0.9% |
Vera Therapeutics Inc | Consumer, Non-cyclical | 0.9% |
EyePoint Pharmaceuticals Inc | Consumer, Non-cyclical | 0.9% |
Upwork Inc | Communications | 0.9% |
Pulmonx Corp | Consumer, Non-cyclical | 0.8% |
Biohaven Ltd | Consumer, Non-cyclical | 0.8% |
Kratos Defense & Security Solutions Inc | Industrial | 0.8% |
Disc Medicine Inc | Consumer, Non-cyclical | 0.8% |
Intra-Cellular Therapies Inc | Consumer, Non-cyclical | 0.8% |
AAR Corp | Industrial | 0.8% |
Intapp Inc | Technology | 0.8% |
Impinj Inc | Technology | 0.8% |
Docebo Inc | Technology | 0.7% |
Veracyte Inc | Consumer, Non-cyclical | 0.7% |
Vita Coco Co Inc/The | Consumer, Non-cyclical | 0.7% |
Fiverr International Ltd | Communications | 0.6% |
Grid Dynamics Holdings Inc | Technology | 0.6% |
Flywire Corp | Consumer, Non-cyclical | 0.5% |
Clear Secure Inc | Technology | 0.5% |
Evolus Inc | Consumer, Non-cyclical | 0.4% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/29/2024
Sector | Weighting | Fund Change from Previous Quarter |
---|
Sector | Weighting | Fund Change from Previous Quarter |
---|---|---|
Communication Services | 2.1% | |
Real Estate | 0.0% | |
Utilities | 0.0% | |
Consumer Discretionary | 0.8% | |
Consumer Staples | 1.6% | |
Energy | 0.0% | |
Financials | 0.7% | |
Health Care | 3.3% | |
Industrials | 1.1% | |
Information Technology | 0.9% | |
Materials | 0.0% |
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 03/28/2024
- $0
- Dividend Frequency
- Annually
Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
---|---|---|---|---|
11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
Record Date | Ex-Dividend Date | Reinvest & Payable Date |
---|---|---|
11/25/2024 | 11/26/2024 | 11/26/2024 |
Capital Gains Distributions
Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
---|---|---|---|---|---|
11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 03/28/2024
Sales Charge | Dealer's Concession | Prices at Breakpoint | |
---|---|---|---|
Less than $50,000 | 5.75% | 5.00% | $15.84 |
$50,000 to $99,999 | 4.75% | 4.00% | $15.67 |
$100,000 to $249,999 | 3.95% | 3.25% | $15.54 |
$250,000 to $499,999 | 2.75% | 2.25% | $15.35 |
$500,000 to $999,999 | 1.95% | 1.75% | $15.23 |
$1,000,000 to $5,000,000 | 0.00% | 1.00% | $14.93 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 02/29/2024
Fund Gross Expense Ratio | Fund Net Expense Ratio | |
---|---|---|
1.37% | 1.37% |
Fund Documents
Fund Documents
0Documents selected
|
||||
---|---|---|---|---|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
Summary Prospectus
Publish Date:11/03/2015
|
||||
Statutory Prospectus
Publish Date:11/03/2015
|
||||
SAI
Publish Date:11/03/2015
|
||||
Annual Report
Publish Date:11/03/2015
|
||||
Semi-Annual Report
Publish Date:11/03/2015
|
||||
Fact Sheet
Publish Date:11/03/2015
|